etofylline clofibrate has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haas, T; Hilgertová, J; Justová, V; Sindelka, G; Skrha, J | 1 |
| Klimes, I; Langrová, H; Linke-Cvrkalová, A; Pleváková, L; Rajecová, E; Rychnavská, E; Seböková, E | 1 |
2 other study(ies) available for etofylline clofibrate and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Relation between hypertriacylglycerolemia and the action of insulin in type 2 diabetes mellitus].
Topics: Adult; Aged; Clofibrate; Diabetes Mellitus, Type 2; Female; Fenofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Insulin Resistance; Male; Middle Aged | 1994 |
[Etofylline clofibrate in the treatment of diabetic dyslipidemia: results of a 6-month period of therapy].
Topics: Clofibrate; Diabetes Mellitus, Type 2; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged | 1995 |